Results 261 to 270 of about 4,110,582 (295)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 1998
Comprehensive evidence-based guidelines for screening and surveillance for colorectal cancer were published in 1997. Backed by compelling scientific data from recently completed controlled trials and case-control studies, these guidelines recommend annual fecal occult blood test screening plus periodic flexible sigmoidoscopy about every 5 years for ...
openaire +2 more sources
Comprehensive evidence-based guidelines for screening and surveillance for colorectal cancer were published in 1997. Backed by compelling scientific data from recently completed controlled trials and case-control studies, these guidelines recommend annual fecal occult blood test screening plus periodic flexible sigmoidoscopy about every 5 years for ...
openaire +2 more sources
Journal of Community Health, 1981
The efficacy of Hemoccult screening for colorectal carcinoma is analyzed utilizing five criteria which a screening test should fulfil before it is used for mass screening. The Hemoccult screening protocol has serious weaknesses. It is at best 83% sensitive for cancer and much less sensitive for polyps.
W B, Applegate, M H, Spector
openaire +4 more sources
The efficacy of Hemoccult screening for colorectal carcinoma is analyzed utilizing five criteria which a screening test should fulfil before it is used for mass screening. The Hemoccult screening protocol has serious weaknesses. It is at best 83% sensitive for cancer and much less sensitive for polyps.
W B, Applegate, M H, Spector
openaire +4 more sources
Screening for Colorectal Cancer
Surgical Clinics of North AmericaColorectal cancer remains the third leading cause of cancer death in the United States. Colorectal cancer screening allows for prevention and early detection of precancerous and cancerous lesions, and screening has been shown to be effective in preventing colorectal cancer deaths. Screening recommendations vary by patient risk profile.
Matthew, Jacobsson +2 more
openaire +4 more sources
Surgical Clinics of North America, 2002
During the past decade we have seen dramatic advances in colon cancer screening. Reduction in mortality in average risk screening for colorectal cancer has now been shown in multiple trials. Efforts to increase public awareness and compliance with evidence-based screening guidelines are underway.
Brad, Trowbridge, Randall W, Burt
openaire +2 more sources
During the past decade we have seen dramatic advances in colon cancer screening. Reduction in mortality in average risk screening for colorectal cancer has now been shown in multiple trials. Efforts to increase public awareness and compliance with evidence-based screening guidelines are underway.
Brad, Trowbridge, Randall W, Burt
openaire +2 more sources
Screening for Colorectal Cancer
New England Journal of Medicine, 1991GOLORECTAL cancer is a leading cause of death from cancer in the United States, with approximately 140,000 new cases and 60,000 deaths per year.1 A 50-year-old person has about a 5 percent risk of having colorectal cancer by the age of 80 and a 2.5 percent risk of dying from it.2 To reduce the morbidity and mortality due to colorectal cancer, some ...
Jane F. Desforges +2 more
openaire +2 more sources
Screening of colorectal cancer
Digestive Diseases and Sciences, 1986Colorectal cancer (CRC) remains a cancer in a disappointing location. However, its location clearly has an advantage that could theoretically permit efficient secondary prevention: the preceding of the cancer by a benign lesion, ie, the adenoma. Complete colonoscopy and its substitute, the double-contrast barium enema, and their specific limitations ...
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2019
This article focuses on programmatic and opportunistic colorectal cancer screening. The pathogenesis and risk factors for colon cancer are discussed. Specific screening tests, screening in high-risk groups, and surveillance recommendations are reviewed.
Nikerson, Geneve +5 more
openaire +2 more sources
This article focuses on programmatic and opportunistic colorectal cancer screening. The pathogenesis and risk factors for colon cancer are discussed. Specific screening tests, screening in high-risk groups, and surveillance recommendations are reviewed.
Nikerson, Geneve +5 more
openaire +2 more sources
Cancer and Metastasis Reviews, 1997
Colorectal cancer occurs throughout the world. Little is known about the etiology of this disease, however, adequate data exist to recommend secondary prevention with mass screening of average risk asymptomatic people age 50 or over. Three randomized controlled trials of a guaiac test for fecal occult blood involving over 250,000 participants found ...
openaire +2 more sources
Colorectal cancer occurs throughout the world. Little is known about the etiology of this disease, however, adequate data exist to recommend secondary prevention with mass screening of average risk asymptomatic people age 50 or over. Three randomized controlled trials of a guaiac test for fecal occult blood involving over 250,000 participants found ...
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1979
To the Editor.— In a recent letter M. J. Goodman, MD (240:2733, 1978), reported 6.8% positive tests for occult blood, using the mail-in Hemoccult (HO) II slides rehydrated before adding the testing reagent, in his colorectal cancer screening study of patients older than 45 years.
openaire +2 more sources
To the Editor.— In a recent letter M. J. Goodman, MD (240:2733, 1978), reported 6.8% positive tests for occult blood, using the mail-in Hemoccult (HO) II slides rehydrated before adding the testing reagent, in his colorectal cancer screening study of patients older than 45 years.
openaire +2 more sources
Screening for colorectal cancer
European Journal of Cancer, 1992J D, Hardcastle, M H, Robinson
openaire +4 more sources